|
시장보고서
상품코드
2127950
항균 카테터 시장 규모, 점유율, 성장, 세계 업계 분석, 지역별 동향 및 예측(2026-2034년)Antimicrobial Catheters Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
항균 카테터 시장의 성장 요인
전 세계 항균 카테터 시장은 2025년에 15억 3,000만 달러로 평가되었으며, 2026년 16억 4,000만 달러에서 2034년까지 28억 달러로 성장하여 예측 기간 중 연평균 성장률(CAGR) 6.9%를 기록할 것으로 전망됩니다. 북미는 카테터 관련 감염증의 높은 유병률, 첨단 의료 인프라, 감염 예방 기술의 적극적인 도입에 힘입어 2025년 37.90%의 점유율로 시장을 주도했습니다.
항균 카테터란 클로르헥시딘,은, 항생제 등의 항균제를 코팅하거나 함침시킨 특수한 의료용 튜브로, 세균의 부착을 억제하고 카테터 관련 요로 감염(CAUTI) 및 카테터 관련 혈류 감염(CRBSI)을 포함한 카테터 관련 감염을 예방하는 것을 목적으로 합니다. 이러한 기기는 병원, 투석 센터, 중환자실, 장기 요양 시설에서 널리 사용되고 있습니다.
시장 개요
수술 건수의 증가, 만성질환 유병률의 상승, 병원내 감염 예방에 대한 의식의 향상로 인해 시장은 꾸준한 성장을 달성하고 있습니다. 의료진은 감염 관련 합병증을 줄이고, 입원 기간을 단축하며, 환자의 예후를 개선하기 위해 항균 카테터의 도입을 점점 더 확대하고 있습니다.
카테터 코팅 및 감염 관리 솔루션 분야의 기술 발전이 시장 확장을 더욱 촉진하고 있습니다. 각 기업은 항균 효과 향상, 보호 효과 지속 시간 연장, 생물막 형성 감소를 실현한 카테터 개발에 주력하고 있습니다.
주요 시장 동향
항균 코팅의 기술적 진보
시장을 형성하는 주요 동향 중 하나는 은계, 클로르헥시딘·은·설파디아진계, 항생제 함유, 용출되지 않는 코팅 등 첨단 항균 코팅의 개발입니다. 이러한 기술은 세균 부착 및 생물막 형성을 최소화하여 투석 환자나 중환자실(ICU) 환자 등 고위험군 환자에 대한 감염 예방 효과를 높입니다.
2023년 11월, CorMedix는 중심정맥 카테터를 사용하는 성인 혈액투석 환자의 CRBSI를 줄이기 위해 설계된 카테터 잠금 용액 ‘DefenCath’에 대해 FDA 승인을 획득했습니다.
시장 촉진요인
외과수술 건수 증가
전 세계에서 수술 건수가 증가하고 있는 것이 주요 성장 요인으로 작용하고 있습니다. 암, 심혈관 질환, 신장 질환 등의 만성질환으로 인해 수액, 투석, 정맥영양에 대한 수요가 높아지고 있으며, 그 결과 중심정맥카테터 및 요도카테터의 사용이 증가하고 있습니다.
미국암협회(American Cancer Society)에 따르면 2022년 전 세계 암 환자 수는 약 2,000만 명으로 추정되며, 이는 카테터를 이용한 치료 및 감염 예방 기기에 대한 수요 증가에 기여하고 있습니다.
또한 의료비 증가와 의료 인프라 확충이 항균 카테터의 보급을 지원하고 있습니다.
시장 억제요인
항균 카테터의 높은 비용
항균 카테터의 높은 비용은 특히 신흥 국가에서 여전히 큰 과제로 남아 있습니다. 많은 의료 시설에서는 예산 제약으로 인해 무균 삽입 기술 및 감염 관리 프로토콜과 결합된 표준 카테터에 계속 의존하고 있습니다.
또한 일부 국가에서는 보험 적용 범위가 제한적이어서 고품질 항균 카테터 기술의 도입이 더욱 제약을 받고 있습니다.
시장 기회
신흥 시장의 의료 시설 확대
중국, 인도, 멕시코 등 국가에서의 병원, 외래 수술 센터, 전문 클리닉의 급속한 확장이 큰 성장 기회를 창출하고 있습니다. 의료비 증가와 수술 건수 증가로 인해 이 지역 전반에 걸쳐 항균 카테터 수요가 견인될 것으로 예상됩니다.
또한 입원 기간 단축, 비용 절감, 감염 위험 감소 등의 이유로 외래 수술 센터에 대한 선호도가 높아지고 있는 점도 시장 성장을 지원하고 있습니다.
세분화 분석
제품 유형별
2025년에는 중심정맥카테터 관련 혈류 감염(CLABSI)의 높은 발생률과 병원내 첨단 중심정맥카테터 사용 증가로 인해 중심정맥카테터 부문이 시장을 주도했습니다.
간헐적 카테터 부문은 예측 기간 중 연평균 성장률(CAGR) 7.6%로 성장할 것으로 예상됩니다.
소재별
2025년에는 입원 환자의 카테터 사용 증가와 내구성이 뛰어나고 생체 적합성이 높은 소재에 대한 수요 증가에 힘입어 실리콘 부문이 37.7%로 가장 큰 점유율을 차지했습니다.
폴리우레탄 부문은 연평균 성장률(CAGR) 7.2%로 성장할 것으로 예측됩니다.
코팅 유형별
2025년에는 생물막 형성 및 카테터 관련 감염 감소에 효과적인 은계 부문이 43.2%의 점유율로 시장을 주도했습니다.
항생제 계열 부문은 연평균 성장률(CAGR) 7.3%로 성장할 것으로 예상됩니다.
최종사용자별
2025년에는 ‘병원 및 당일 수술 센터(ASC)’ 부문이 시장을 주도할 것이며, 전 세계 외과수술 건수의 증가와 병원 인프라 확충을 배경으로 2026년에는 시장 점유율의 69.5%를 차지할 것으로 예측됩니다.
지역별 분석
북미
북미는 2025년에 5억 8,000만 달러의 시장 규모를 기록하며, 계속해서 지역별 시장에서 1위를 유지했습니다. 이 지역은 많은 수술 건수, 충실한 감염 예방 프로그램, 혁신적인 카테터 기술의 급속한 보급이라는 혜택을 받고 있습니다.
미국 시장은 2026년에 5억 3,000만 달러에 달할 것으로 예측됩니다.
유럽
유럽 시장은 수술 건수의 증가와 첨단 항균 기기의 보급 확대에 힘입어 2026년에는 4억 4,000만 달러에 달할 것으로 예상됩니다.
2026년에는 독일이 8,000만 달러, 영국이 7,000만 달러에 달할 것으로 예측됩니다.
아시아태평양
아시아태평양은 의료 인프라 확충과 감염 방지 솔루션에 대한 수요 증가에 힘입어 2026년에는 4억 3,000만 달러에 달할 것으로 예측됩니다.
중국은 1억 4,000만 달러, 인도는 7,000만 달러, 일본은 9,000만 달러에 달할 것으로 예측됩니다.
최근 동향으로는 새로운 항균성 중심정맥 카테터, FDA 승인, 전략적 제휴, 감염 예방 연구 구상의 확대 등이 있습니다.
목차
제1장 서론
제2장 개요
제3장 시장 역학
제4장 주요 인사이트
제5장 세계의 항균 카테터 시장 분석, 인사이트, 예측, 2021-2034년
제6장 북미의 항균 카테터 시장 분석, 인사이트, 예측, 2021-2034년
제7장 유럽의 항균 카테터 시장 분석, 인사이트, 예측, 2021-2034년
제8장 아시아태평양의 항균 카테터 시장 분석, 인사이트, 예측, 2021-2034년
제9장 라틴아메리카의 항균 카테터 시장 분석, 인사이트, 예측, 2021-2034년
제10장 중동 및 아프리카의 항균 카테터 시장 분석, 인사이트, 예측, 2021-2034년
제11장 경쟁 분석
KSA 26.09.15Growth Factors of antimicrobial catheters Market
The global antimicrobial catheters market was valued at USD 1.53 billion in 2025 and is projected to grow from USD 1.64 billion in 2026 to USD 2.80 billion by 2034, registering a CAGR of 6.9% during the forecast period. North America dominated the market with a 37.90% share in 2025, supported by a high prevalence of catheter-associated infections, advanced healthcare infrastructure, and strong adoption of infection-prevention technologies.
Antimicrobial catheters are specialized medical tubes coated or infused with antimicrobial agents such as chlorhexidine, silver, and antibiotics to reduce bacterial colonization and prevent catheter-associated infections, including Catheter-Associated Urinary Tract Infections (CAUTIs) and Catheter-Related Bloodstream Infections (CRBSIs). These devices are widely used in hospitals, dialysis centers, intensive care units, and long-term care settings.
Market Overview
The market is experiencing steady growth due to increasing surgical procedures, rising chronic disease prevalence, and growing awareness regarding hospital-acquired infection prevention. Healthcare providers are increasingly adopting antimicrobial catheters to reduce infection-related complications, shorten hospital stays, and improve patient outcomes.
Technological advancements in catheter coatings and infection-control solutions are further driving market expansion. Companies are focusing on developing catheters with enhanced antimicrobial efficacy, longer-lasting protection, and reduced biofilm formation.
Key Market Trend
Technological Advancements in Antimicrobial Coatings
A major trend shaping the market is the development of advanced antimicrobial coatings, including silver-based, chlorhexidine-silver sulfadiazine, antibiotic-infused, and non-leaching coatings. These technologies help minimize bacterial adhesion and biofilm formation, offering better protection against infections in high-risk patients such as dialysis users and ICU patients.
In November 2023, CorMedix Inc. received FDA approval for DefenCath, a catheter lock solution designed to reduce CRBSIs in adult hemodialysis patients using central venous catheters.
Market Drivers
Increasing Number of Surgical Procedures
The rising volume of surgical procedures worldwide is a major growth driver. Chronic diseases such as cancer, cardiovascular disorders, and kidney disease are increasing the demand for fluid administration, dialysis, and parenteral nutrition, thereby boosting the use of central venous and urinary catheters.
According to the American Cancer Society, approximately 20 million cancer cases were estimated globally in 2022, contributing to higher demand for catheter-based therapies and infection-prevention devices.
Additionally, growing healthcare expenditure and expansion of healthcare infrastructure are supporting wider adoption of antimicrobial catheters.
Market Restraints
High Cost of Antimicrobial Catheters
The high cost of antimicrobial catheters remains a significant challenge, particularly in emerging economies. Many healthcare facilities continue to rely on standard catheters combined with sterile insertion techniques and infection-control protocols due to budget limitations.
Limited reimbursement policies in several countries further restrict the adoption of premium antimicrobial catheter technologies.
Market Opportunities
Expansion of Healthcare Facilities in Emerging Markets
Rapid expansion of hospitals, ambulatory surgical centers, and specialty clinics in countries such as China, India, and Mexico is creating substantial growth opportunities. Increasing healthcare spending and rising surgical volumes are expected to drive demand for antimicrobial catheters across these regions.
The growing preference for ambulatory surgical centers due to shorter stays, lower costs, and reduced infection risks is also supporting market growth.
Segmentation Analysis
By Product Type
The central venous catheters segment dominated the market in 2025 due to the high incidence of Central Line-Associated Bloodstream Infections (CLABSIs) and increasing use of advanced central venous catheters in hospitals.
The intermittent catheters segment is expected to grow at a CAGR of 7.6% during the forecast period.
By Material
The silicone segment held the largest share at 37.7% in 2025, supported by rising catheter usage in hospitalized patients and increasing demand for durable, biocompatible materials.
The polyurethane segment is projected to grow at 7.2% CAGR.
By Coating Type
The silver-based segment led the market with a 43.2% share in 2025, driven by its effectiveness in reducing biofilm formation and catheter-associated infections.
The antibiotic-based segment is expected to grow at 7.3% CAGR.
By End User
The hospitals & ASCs segment dominated the market in 2025 and is projected to hold 69.5% of the market in 2026, supported by increasing surgical procedures and growing hospital infrastructure worldwide.
Regional Analysis
North America
North America generated USD 0.58 billion in 2025 and remained the leading regional market. The region benefits from high surgical volumes, strong infection-prevention programs, and rapid adoption of innovative catheter technologies.
The U.S. market is projected to reach USD 0.53 billion in 2026.
Europe
Europe is expected to reach USD 0.44 billion in 2026, driven by increasing surgical procedures and growing adoption of advanced antimicrobial devices.
Germany is projected to reach USD 0.08 billion and the U.K. USD 0.07 billion in 2026.
Asia Pacific
Asia Pacific is projected to reach USD 0.43 billion in 2026, supported by expanding healthcare infrastructure and rising demand for infection-control solutions.
China is expected to generate USD 0.14 billion, while India and Japan are projected to reach USD 0.07 billion and USD 0.09 billion, respectively.
Competitive Landscape
The market is moderately consolidated, with major players focusing on product innovation, clinical studies, partnerships, and acquisitions.
Key companies include:
- Cardinal Health
- Teleflex Incorporated
- Cook Medical
- B. Braun SE
- Bactiguard AB
- Vygon
- Kimal
- Spectrum Vascular
Recent developments include new antimicrobial central venous catheters, FDA approvals, strategic partnerships, and expansion of infection-prevention research initiatives.
Conclusion
The antimicrobial catheters market is expected to grow from USD 1.53 billion in 2025 to USD 2.80 billion by 2034, driven by rising catheter-associated infections, increasing surgical procedures, and continuous technological innovation. While high device costs remain a challenge, expanding healthcare infrastructure, growing awareness of infection prevention, and the introduction of advanced antimicrobial coatings are expected to create strong long-term growth opportunities. North America currently leads the market, while Asia Pacific is emerging as a rapidly growing region for future expansion.
Segmentation By Product Type, Material, Coating Type, End User, and Region
By Product Type * Central Venous Catheters
- Urinary Catheters
- Intermittent Catheters
- Others
By Material * Silicone
- Polyurethane
- Latex
- Others
By Coating Type * Silver-based
- Antibiotic-based
- Others
By End User * Hospitals & ASCs
- Specialty Clinics
- Homecare Settings
- Others
By Region * North America (By Product Type, By Material, By Coating Type, By End User, and by Country)
- U.S. (By Coating Type)
- Canada (By Coating Type)
- Europe (By Product Type, By Material, By Coating Type, By End User, and by Country/Sub-region)
- U.K. (By Coating Type)
- Germany (By Coating Type)
- France (By Coating Type)
- Italy (By Coating Type)
- Spain (By Coating Type)
- Scandinavia (By Coating Type)
- Rest of Europe (By Coating Type)
- Asia Pacific (By Product Type, By Material, By Coating Type, By End User, and by Country/Sub-region)
- China (By Coating Type)
- Japan (By Coating Type)
- India (By Coating Type)
- Australia (By Coating Type)
- Southeast Asia (By Coating Type)
- Rest of Asia Pacific (By Coating Type)
- Latin America (By Product Type, By Material, By Coating Type, By End User, and by Country/Sub-region)
- Brazil (By Coating Type)
- Mexico (By Coating Type)
- Rest of Latin America (By Coating Type)
- Middle East & Africa (By Product Type, By Material, By Coating Type, By End User, and by Country/Sub-region)
- GCC (By Coating Type)
- South Africa (By Coating Type)
- Rest of the Middle East & Africa (By Coating Type)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 3.5. Market Challenges
4. Key Insights
- 4.1. Number of Surgical Procedures, Key Countries/Region, 2025
- 4.2. Technological Advancements in Antimicrobial Catheters
- 4.3. New Product Launches, Key Players
- 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships
5. Global Antimicrobial Catheters Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product Type
- 5.1.1. Central Venous Catheters
- 5.1.2. Urinary Catheters
- 5.1.3. Intermittent Catheters
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - By Material
- 5.2.1. Silicone
- 5.2.2. Polyurethane
- 5.2.3. Latex
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - By Coating Type
- 5.3.1. Silver-based
- 5.3.2. Antibiotic-based
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Hospitals & ASCs
- 5.4.2. Specialty Clinics
- 5.4.3. Homecare Settings
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Antimicrobial Catheters Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product Type
- 6.1.1. Central Venous Catheters
- 6.1.2. Urinary Catheters
- 6.1.3. Intermittent Catheters
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - By Material
- 6.2.1. Silicone
- 6.2.2. Polyurethane
- 6.2.3. Latex
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast - By Coating Type
- 6.3.1. Silver-based
- 6.3.2. Antibiotic-based
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Hospitals & ASCs
- 6.4.2. Specialty Clinics
- 6.4.3. Homecare Settings
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.1.1. By Coating Type
- 6.5.2. Canada
- 6.5.2.1. By Coating Type
- 6.5.1. U.S.
7. Europe Antimicrobial Catheters Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product Type
- 7.1.1. Central Venous Catheters
- 7.1.2. Urinary Catheters
- 7.1.3. Intermittent Catheters
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - By Material
- 7.2.1. Silicone
- 7.2.2. Polyurethane
- 7.2.3. Latex
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast - By Coating Type
- 7.3.1. Silver-based
- 7.3.2. Antibiotic-based
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Hospitals & ASCs
- 7.4.2. Specialty Clinics
- 7.4.3. Homecare Settings
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K.
- 7.5.1.1. By Coating Type
- 7.5.2. Germany
- 7.5.2.1. By Coating Type
- 7.5.3. France
- 7.5.3.1. By Coating Type
- 7.5.4. Spain
- 7.5.4.1. By Coating Type
- 7.5.5. Italy
- 7.5.5.1. By Coating Type
- 7.5.6. Scandinavia
- 7.5.6.1. By Coating Type
- 7.5.7. Rest of Europe
- 7.5.7.1. By Coating Type
- 7.5.1. U.K.
8. Asia Pacific Antimicrobial Catheters Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product Type
- 8.1.1. Central Venous Catheters
- 8.1.2. Urinary Catheters
- 8.1.3. Intermittent Catheters
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - By Material
- 8.2.1. Silicone
- 8.2.2. Polyurethane
- 8.2.3. Latex
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast - By Coating Type
- 8.3.1. Silver-based
- 8.3.2. Antibiotic-based
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Hospitals & ASCs
- 8.4.2. Specialty Clinics
- 8.4.3. Homecare Settings
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.1.1. By Coating Type
- 8.5.2. Australia
- 8.5.2.1. By Coating Type
- 8.5.3. China
- 8.5.3.1. By Coating Type
- 8.5.4. India
- 8.5.4.1. By Coating Type
- 8.5.5. Southeast Asia
- 8.5.5.1. By Coating Type
- 8.5.6. Rest of Asia Pacific
- 8.5.6.1. By Coating Type
- 8.5.1. Japan
9. Latin America Antimicrobial Catheters Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product Type
- 9.1.1. Central Venous Catheters
- 9.1.2. Urinary Catheters
- 9.1.3. Intermittent Catheters
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - By Material
- 9.2.1. Silicone
- 9.2.2. Polyurethane
- 9.2.3. Latex
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast - By Coating Type
- 9.3.1. Silver-based
- 9.3.2. Antibiotic-based
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Hospitals & ASCs
- 9.4.2. Specialty Clinics
- 9.4.3. Homecare Settings
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.1.1. By Coating Type
- 9.5.2. Mexico
- 9.5.2.1. By Coating Type
- 9.5.3. Rest of Latin America
- 9.5.3.1. By Coating Type
- 9.5.1. Brazil
10. Middle East & Africa Antimicrobial Catheters Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product Type
- 10.1.1. Central Venous Catheters
- 10.1.2. Urinary Catheters
- 10.1.3. Intermittent Catheters
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - By Material
- 10.2.1. Silicone
- 10.2.2. Polyurethane
- 10.2.3. Latex
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast - By Coating Type
- 10.3.1. Silver-based
- 10.3.2. Antibiotic-based
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Hospitals & ASCs
- 10.4.2. Specialty Clinics
- 10.4.3. Homecare Settings
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. GCC
- 10.5.1.1. By Coating Type
- 10.5.2. South Africa
- 10.5.2.1. By Coating Type
- 10.5.3. Rest of Middle East & Africa
- 10.5.3.1. By Coating Type
- 10.5.1. GCC
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Cook Medical
- 11.2.2. B. Braun SE
- 11.2.3. BACTIGUARD AB
- 11.2.4. Vygon
- 11.2.5. Kimal
- 11.2.6. Sterimed Group
- 11.2.7. AVNS
- 11.2.8. Spectrum Vascular
- 11.2.9. Cardinal Health
- 11.2.10. Teleflex Incorporated
